Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Inhaled Ethanolic Solutions on Breath Alcohol
NCT02264145Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 1998
- Primary completion
- Dec 1998
01
Overview
Phase 1, randomised, open-label trial (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Area under curve of blood alcohol level estimated from breath alcohol concentration. Started Nov 1998; status: completed.
Beyond the preview
Go deeper on NCT02264145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264145.